USA/UBS
In perhaps the largest corporate criminal tax settlement since GlaxoSmithKline Plc agreed to pay the Internal Revenue Service $3.4 billion in 2006, UBS AG shelled out $780 million to U.S. agencies under a deferred prosecution agreement. Prosecutors alleged that it helped American clients evade U.S. taxes.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
